Tazbentetol is an investigational, once-daily synaptic regenerative therapy designed to restore cognitive and motor function in ALS.

According to the CDC, around 5,000 people in the U.S. are diagnosed with ALS every year. There is no cure for this neurological illness. Although anglers across the Northland were taking advantage of ...

The agency said NfL could be used as a marker to predict patient benefit, but more data is still needed to confirm that link.

There could be new hope for ALS management as a promising drug enters phase 3 clinical trials. ALS is a progressive disease in which the brain loses connection with the muscles, The ALS Association ...

The search for an ALS cure, which has remained a mystery to the health care community, is now being sought out with the help of artificial intelligence. AI is being used to better coordinate all the ...

It's a terminal disease, currently with no cure. ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the Valley that can hopefully ...

We're looking at amyotrophic lateral sclerosis, or ALS. It's a disease where the cause is unknown, there is no cure, there ...

The ALS Network’s 23rd annual Inland Empire Walk and Roll to Cure ALS, formerly the Walk to Defeat ALS, will be held Oct. 19 at Miller Park Amphitheater, 17002 Arrow Blvd., Fontana. The Walk and Roll ...

In a June 2025 interview, Dane shared that his ALS symptoms had started about a year and a half prior — late 2023 or early ...